Breaking News, Collaborations & Alliances

LakePharma, NJ Bio Form ADC Alliance

To provide streamlined antibody-drug conjugate services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

LakePharma, a biologics contract research development and manufacturing organization (CRDMO), and NJ Biopharmaceuticals, a contract research organization (CRO) providing integrated chemistry and biology services, have formed an alliance to offer streamlined antibody-drug conjugate (ADC) development solutions for the biotechnology and pharmaceutical sectors.   LakePharma has been a supplier of novel antibodies for over 10 years, and NJ Bio has expertise in linker-payload synthesis and bioconjugat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters